The regulatory file for whey protein hydrolysate
Whey protein hydrolysate is a dairy ingredient, so the milk allergen declaration follows every pack into every market that keeps an allergen list. In the European Union the declaration sits under Regulation (EU) No 1169/2011 Annex II; in the United States it sits under FALCPA. Hydrolysis shortens the peptides but does not make the powder milk-free, and the finished product's route and claims remain the buyer's regulatory decision, so this page lists the documents and checks rather than promising a market.
Hydrolysis shortens the peptides but does not remove the allergen: every whey hydrolysate lot carries the milk declaration, and a hydrolysate cannot be declared milk-free on a food or supplement label.
What the file contains
The file holds four things: the specification version with the degree of hydrolysis, the certificate that releases the lot, the allergen and origin statements, and the record of how source, enzyme, process and pack changes are handled. The certificate describes the lot, the TDS carries the specification and the safety data sheet covers handling. None of the three settles the finished product's category, which is recorded separately.
Whey protein is a traditional dairy ingredient — not a novel food in the EU and not a food additive in either market — as of this review. That does not make every finished product suitable: a supplement, a beverage, a bar and an infant formula sit in different categories, and the category sets the limits, the labelling and the claims. The ingredient paperwork supports the category decision; it does not replace it.
Great Britain keeps its own labelling rules, while Northern Ireland follows the EU text. Which set applies turns on the delivery address, and the buyer's regulatory team notes that decision on the order.
European Union
Regulation (EU) No 1169/2011 requires the milk declaration in the ingredient list, emphasised by typography so that it stands out from the other ingredients. “Whey protein hydrolysate (milk)” is the form a reader expects; a declaration in a footnote, or an allergen statement separated from the ingredient list, is not the same thing. Framework references are gathered in the EU regulatory notes.
General food law, Regulation (EC) No 178/2002, sets the traceability duty; Regulation (EU) 2023/915, which replaced 1881/2006, sets contaminant limits; Regulation (EC) No 1924/2006 governs nutrition and health claims; Directive 2002/46/EC covers food supplements. An infant formula made with a hydrolysate sits under its own delegated regulation and is not covered by a general food-grade specification. Check the consolidated text in force at the time of sale, because all of these instruments are amended.
United States
Milk is a major food allergen under FALCPA, so the label carries either “Contains: milk” or the milk in parentheses after the ingredient. A hydrolysed whey protein is still milk protein for that purpose. The ingredient statement, the Nutrition Facts panel and any structure/function statement are reviewed together, and the DSHEA disclaimer belongs with the claim, not in a separate document.
The protein declaration uses the 50 g Daily Value, so 20 g is 40% of it. A “good source” claim covers 10–19% and “high” or “excellent source” 20% or more. A protein claim also brings the protein-quality calculation into the label review, and the serving size decides the arithmetic. The US regulatory notes set out the framework.
Contaminants and limits
The contaminant panel on the ingredient is per element. The limits for the finished product follow from the dose, so a drum result and a label claim are two different checks.
| Parameter | Reference for a supplement | Evidence the file should hold |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | The lot figure, the method and the dose calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | The lot figure and any category exception |
| Mercury (Hg) | 0.10 mg/kg in the supplement | The lot figure and the method |
| Arsenic (As) | Limit set by the buyer or the market | The agreed limit and method, printed on the certificate |
The catalogue micro panel — APC ≤1,000 cfu/g, yeast and mould ≤100 cfu/g, E. coli and Salmonella absent — is the release gate for the powder, not the food-safety criterion for the finished product, which depends on the process and the pack. The heavy-metal results are measured by ICP-MS and should be reported per element, not as a sum.
Claims and the label
A protein claim is arithmetic. EU nutrition claims set the bar at 12% of energy for “source of protein” and 20% for “high protein”; 20 g of protein is 80 kcal, so “high protein” needs a serving of no more than 400 kcal. In the US the same 20 g is 40% of the Daily Value. The NRV glossary entry and the Daily Value entry give the reference numbers behind those percentages.
“Hydrolysed” describes the process, not a benefit. No authorised claim in either market says that a hydrolysed protein is easier to digest, and “predigested” is marketing language rather than a permitted claim. “Hypoallergenic” belongs to the infant-formula and medical-food framework, not to a general food or supplement, and it cannot be used for this powder. Neither market leaves room for a disease claim, and this site publishes specifications rather than health claims.
The milk declaration is the one label element that no formulation change removes. A brand that wants to present the product as suitable for people avoiding dairy has to reformulate, not reword. Lactose is a separate point: the catalogue limit is ≤2.0%, which is not a lactose-free product, and the “lactose-free” thresholds in the destination market are far lower than that.
Documents for the file
The file needs a certificate with the protein figure on a dry basis and the degree of hydrolysis with its method, plus the specification version, the TDS and the SDS. Add the allergen statement for the material and the pack, the origin and manufacturing site, the dairy health certificate where the destination requires one, a GMO statement, and Kosher or Halal papers if asked for. The identity page lists the analytical evidence behind the claim that the powder is a hydrolysate.
The supplier keeps the source, the enzyme, the process and the pack under change control; the buyer keeps the market route, the dose as sold and the label review. Both sides should be able to point to the same specification revision when a label is signed off.
Checklist before the first order
- Specification version, protein basis and degree of hydrolysis are named.
- COA, TDS, SDS, allergen, origin and GMO statements are on file.
- The milk declaration and the lactose position have been checked against the destination text.
- Contaminant figures are converted to the dose as sold.
- The claim and the label have been reviewed for the market, with no hydrolysed-protein benefit implied.
- Source, enzyme and process are under change control, and the certificate matches the pack.
The product page carries the catalogue specification, and the quality page describes the release file that supports these documents.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation